600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA

Conditions

Healthy

Phase 1

600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting Conditions

CompletedNCT00840099

Teva Pharmaceuticals USAHealthy

Start: 2002-08-31End: 2002-08-31Updated: 2024-08-20

600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed Conditions

CompletedNCT00840840

Teva Pharmaceuticals USAHealthy

Start: 2002-08-31End: 2002-08-31Updated: 2024-08-20